Journal profile · Medicine-Oncology
Annual Review of Cancer Biology
ISSN 2472-3428 · Annual Reviews Inc. · UNITED STATES
Annual Review of Cancer Biology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.34; subscription journal; 22 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Annual Review of Cancer Biology is published by Annual Reviews Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation and CAR-T cell therapy research, together about 24.8% of its articles. Its main subfields are Molecular Biology and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
AIMS AND SCOPE OF JOURNAL: The Annual Review of Cancer Biology reviews a range of subjects in cancer research that represent important and emerging areas in the field. With recent advances in our understanding of the basic mechanisms of cancer development and the translation of an increasing number of these findings into the clinic in the form of targeted treatments for the disease, the Annual Review of Cancer Biology is divided into three broad themes: Cancer Cell Biology, Tumorigenesis and Cancer Progression, and Translational Cancer Science.  
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology9.2%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology8%
- CAR-T cell therapy researchMedicine7.7%
- Protein Degradation and InhibitorsBiochemistry, Genetics and Molecular Biology7%
- Cancer Immunotherapy and BiomarkersMedicine5.8%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology5.2%
- Cancer Cells and MetastasisMedicine4.9%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.34LetPub ·
- Impact factor (publisher)
- 5.5Publisher website ·
- CiteScore 2026-06
- 10LetPub ·
- SJR 2026-06
- 2.72LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 51OpenAlex ·
- i10-index
- 147OpenAlex ·
- 2-year mean citedness
- 4.11OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 16LetPub ·
Articles by year OpenAlex count · 229 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 8 | 7 | 0 |
| 2025 | 22 | 21 | 24 |
| 2024 | 26 | 26 | 206 |
| 2023 | 29 | 28 | 618 |
| 2022 | 10 | 10 | 192 |
| 2021 | 13 | 13 | 406 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Annual Reviews Inc.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2472-3428
- Official links
- Journal homepage ↗OpenAlex
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Annual Review of Cancer Biology
What CAS zone is Annual Review of Cancer Biology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Annual Review of Cancer Biology is in Zone 2 of Medicine, and in Zone 3 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Annual Review of Cancer Biology?
The latest impact factor listed by LetPub is 5.34; CiteScore 10, h-index 51.
Which databases index Annual Review of Cancer Biology?
According to LetPub and DOAJ records, Annual Review of Cancer Biology is indexed in SCIE and Scopus.
Is Annual Review of Cancer Biology open access, and what is the APC?
Annual Review of Cancer Biology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .